Hepatitis C Virus (HCV) Updates: Recommendations for Managing and Treating Hepatitis C

New Orleans, LA US
February 20, 2020

In the United States, more than 2.4 million people have a diagnosis of Hepatitis C Virus. Hepatitis C is a contagious liver disease spread through contact with the blood of a person who has the virus. It can result in serious liver damage, including liver failure. There are different types of Hep C, called genotypes. Genotypes 1-6 are the most common. Knowing which genotype patients have is important for their treatment. Understanding how to monitor the medications for hepatitis C and the duration of therapy of the medications will help pharmacists and pharmacy technicians be able to track if a medication is effective for a patient. Healthcare professionals will know what to look out for in terms of each medication’s monitoring parameters in order to ensure a better safety profile for the patients. The presentation will cover the updates in treatment options available for Hepatitis C. The focus of this presentation will be to evaluate and discuss the evidence supporting the evidence of Hepatitis C treatment updates. The evidence will be applied to patient cases to assess learning. 

Target Audience

  • Pharmacists
  • Pharmacy technicians

Learning Objectives

Pharmacist learning objectives

  1. Recall how to design a  treatment plan for initial Hepatitis C virus (HCV) patients based on updates with a focus on shortened duration of glecaprevir/pibrentasir treatment and elimination of renal adjustments for sofubuvir-based regimens
  2. Describe how to manage HCV in the pediatric population according to updated guidelines and FDA package labels

Pharmacy technician learning objectives

  1. Discuss Hepatitis C virus (HCV) transmission and define pertinent lab values
  2. Recognize brand/generic names of medications discussed in the updated guidelines and applicable package inserts
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CEU – Attendance
Course opens: 
Course expires: 
Event starts: 
02/20/2020 - 12:00pm CST
Event ends: 
02/20/2020 - 1:00pm CST
Ochsner Medical Center
1514 Jefferson Hwy.
New Orleans, LA 70121
United States

Relevant financial relationships: Planning committee members and presenters have nothing to disclose


Claire Ozoral, PharmD, BCPS
Hepatology Clinical Pharmacist
Ochsner Specialty Pharmacy
Sheena Babin, PharmD, CSP
Manager, Pharmacy Clinical Services and Business Development
Ochsner Specialty Pharmacy



Katrina K. Harper, PharmD, MBA, BCPS, BCSCP
Clinical Pharmacy Director, Sourcing Operations
Center for Pharmacy Practice Excellence



Alaa Elsayed, PharmD
Community Pharmacy Resident, PGY-1
Ochsner Specialty Pharmacy
Joint Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and Ochsner Medical Center.  Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Designation Statements:
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-20-040-L01-P
Universal Activity Number: JA0006103-9999-20-040-L01-T
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CEU – Attendance


Please login or register to take this course.